FI862590A0 - PHARMACEUTICAL PRODUCT. - Google Patents

PHARMACEUTICAL PRODUCT.

Info

Publication number
FI862590A0
FI862590A0 FI862590A FI862590A FI862590A0 FI 862590 A0 FI862590 A0 FI 862590A0 FI 862590 A FI862590 A FI 862590A FI 862590 A FI862590 A FI 862590A FI 862590 A0 FI862590 A0 FI 862590A0
Authority
FI
Finland
Prior art keywords
pharmaceutical product
pharmaceutical
product
Prior art date
Application number
FI862590A
Other languages
Finnish (fi)
Other versions
FI862590A (en
Inventor
Walter Klose
Gerald Kirsch
Andreas Huth
Wolfgang Froehlich
Henry Laurent
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of FI862590A publication Critical patent/FI862590A/en
Publication of FI862590A0 publication Critical patent/FI862590A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F02—COMBUSTION ENGINES; HOT-GAS OR COMBUSTION-PRODUCT ENGINE PLANTS
    • F02B—INTERNAL-COMBUSTION PISTON ENGINES; COMBUSTION ENGINES IN GENERAL
    • F02B1/00—Engines characterised by fuel-air mixture compression
    • F02B1/02—Engines characterised by fuel-air mixture compression with positive ignition
    • F02B1/04—Engines characterised by fuel-air mixture compression with positive ignition with fuel-air mixture admission into cylinder

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI862590A 1984-10-19 1986-06-17 PHARMACEUTICAL PRODUCT. FI862590A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19843438839 DE3438839A1 (en) 1984-10-19 1984-10-19 PHARMACEUTICAL PREPARATIONS
PCT/DE1985/000472 WO1986002268A1 (en) 1984-10-19 1985-10-18 Pharmaceutical preparations

Publications (2)

Publication Number Publication Date
FI862590A FI862590A (en) 1986-06-17
FI862590A0 true FI862590A0 (en) 1986-06-17

Family

ID=6248597

Family Applications (1)

Application Number Title Priority Date Filing Date
FI862590A FI862590A0 (en) 1984-10-19 1986-06-17 PHARMACEUTICAL PRODUCT.

Country Status (8)

Country Link
EP (1) EP0198919B1 (en)
JP (2) JPH0742229B2 (en)
AU (2) AU5095885A (en)
DE (2) DE3438839A1 (en)
DK (1) DK167531B1 (en)
FI (1) FI862590A0 (en)
NO (1) NO164897C (en)
WO (1) WO1986002268A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5783591A (en) * 1984-10-19 1998-07-21 Schering Aktiengesellschaft Administration of oxazolidinone and pyrolidinone compounds for the treatment of inflammation
US4681940A (en) * 1985-11-19 1987-07-21 American Home Products Corporation 5-[3-[[2-quinolyl]methoxy]phenyl]-1,3-oxazoles
DE3639225A1 (en) * 1986-11-14 1988-05-19 Schering Ag USE OF 5- (SUBST. PHENYL) -OXAZOLIDINONE DERIATES AS PSYCHOPHARMAKA
HU203330B (en) * 1987-06-10 1991-07-29 Pfizer Process for producing oxazolidin-2-one derivatives and hypoglychemic pharmaceutical compositions containing them
ATE106243T1 (en) * 1988-03-24 1994-06-15 Sankyo Co USE OF ISOXAZOLINONES AS CEREBRO-ACTIVE MEDICATIONS.
DE69128627T2 (en) * 1990-08-03 1998-07-02 Smithkline Beecham Corp TNF INHIBITORS
US5124455A (en) * 1990-08-08 1992-06-23 American Home Products Corporation Oxime-carbamates and oxime-carbonates as bronchodilators and anti-inflammatory agents
US5547979A (en) * 1992-03-30 1996-08-20 Smithkline Beecham TNF inhibition
JPH11500110A (en) * 1995-02-10 1999-01-06 シエーリング アクチエンゲゼルシヤフト TNF-suppressing preparation
DE19540475A1 (en) * 1995-10-20 1997-04-24 Schering Ag Chiral methylphenyloxazolidinones
US6770658B2 (en) * 1998-09-09 2004-08-03 Inflazyme Pharmaceuticals Ltd. Substituted γ-phenyl-Δ-lactams and uses related thereto
RU2340600C2 (en) * 2001-10-16 2008-12-10 Мемори Фармасьютиклз Корпорейшн Derivatives of 4-(4-alkoxy-3-hydroxyphenyl)-2-pyrrolidone as pde-4 inhibitors for treatment of neurological syndromes
WO2004098592A1 (en) * 2003-05-06 2004-11-18 Senju Pharmaceutical Co. Ltd. Composition containing oxazolidinone derivative
TW200732313A (en) 2005-12-15 2007-09-01 Astrazeneca Ab Oxazolidinone compounds and their use as metabotropic glutamate receptor potentiators

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2413935A1 (en) * 1974-03-20 1975-10-16 Schering Ag 4- (POLYALCOXY-PHENYL) -2-PYRROLIDONE
DE2655369A1 (en) * 1976-12-03 1978-06-08 Schering Ag 5- (SUBST. PHENYL) -OXAZOLIDINONE AND THEIR SULFUR ANALOGS AND PROCESS FOR THEIR PRODUCTION
SU888821A3 (en) * 1976-12-03 1981-12-07 Шеринг Аг (Инофирма) Method of preparing 5-(substituted phehyl)-oxazolidinones or their sulphur-containing analogs

Also Published As

Publication number Publication date
NO164897C (en) 1990-11-28
JPH0742229B2 (en) 1995-05-10
NO164897B (en) 1990-08-20
WO1986002268A1 (en) 1986-04-24
JPS62501289A (en) 1987-05-21
NO862439D0 (en) 1986-06-18
DK167531B1 (en) 1993-11-15
DK288686A (en) 1986-06-19
FI862590A (en) 1986-06-17
EP0198919B1 (en) 1990-02-28
JP2669494B2 (en) 1997-10-27
AU5095885A (en) 1986-05-02
DE3576118D1 (en) 1990-04-05
EP0198919A1 (en) 1986-10-29
DK288686D0 (en) 1986-06-19
JPH0761978A (en) 1995-03-07
DE3438839A1 (en) 1986-04-24
AU4765390A (en) 1990-05-03
NO862439L (en) 1986-06-18

Similar Documents

Publication Publication Date Title
FI821123L (en) LOCAL ANVAENDBARA PHARMACEUTICAL PRODUCT
DE3582124D1 (en) ABSORBABLE CALCITONINE MEDICINAL PRODUCT.
FI842395A0 (en) 13 -ALKYLGONANER, DERAS FRAMSTAELLNING OCH DESSA INNEHAOLLANDE PHARMACEUTICAL PRODUCT.
FI875326A (en) LJUSBESTRAOLNINGSANORDNING FOER MEDICINAL VAORD AV OERA.
FI872114A0 (en) FOERFARANDE FOER TRYCKNING AV FORMADE PRODUCT HAERLEDDA FRAON ARAMIDFIBRER.
DE3676248D1 (en) MEDICINAL PRODUCTS CONTAINING UBIDECARENON.
DE3667381D1 (en) ABSORBENT PRODUCT.
FI880195A (en) THERAPEUTIC PRODUCT.
FI863077A (en) PHARMACEUTICAL PARTICULARS.
FI854573A (en) PHARMACEUTICAL KAPSLAR MED FOERDROEJD FRIGOERING.
FI850455A0 (en) PHARMACEUTICAL PRODUCT.
FI862590A0 (en) PHARMACEUTICAL PRODUCT.
FI875167A (en) KALLVALSAD BANDSTAOL PRODUCT.
DE3763519D1 (en) MEDICINAL PRODUCTS.
FI852658L (en) PHARMACEUTICAL AEMNEN.
FI863382A0 (en) SUBSTITUTE TOLUIDINER, FOERFARANDE FOER DERAS FRAMSTAELLNING, DESSA INNEHAOLLANDE PHARMACEUTICAL PRODUCT OCH DERAS ANVAENDNING FOER HAEMMANDE AV MAGSYRASEKRET.
FI901938A0 (en) SILVERSULFADIAZINE INNEHAOLLANDE PHARMACEUTICAL PRODUCT FOER LOCAL EXTERNT BRUK.
FI880744A (en) PIPERAZINKARBOXYLSYRA, DESS FRAMSTAELLNING OCH DENNA INNEHAOLLANDE PHARMACEUTICAL PRODUCT.
FI844153L (en) 1,2-DITIOLANDERIVAT, DERAS FRAMSTAELLNINGSFOERFARANDE, DESSA INNEHAOLLANDE PHARMACEUTICAL PRODUCT OCH DERAS ANVAENDNING.
ES297038Y (en) PHARMACEUTICAL TABLET.
FI810934L (en) PHARMACEUTICAL PRODUCT
FI875616A (en) PHARMACEUTICAL BLANDNINGAR.
FI803846L (en) PHARMACEUTICAL PRODUCT
DE3781045D1 (en) ANTIRHEUMATIC MEDICINAL PRODUCT.
FI822980A0 (en) FURANOKROMONDERIVAT, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DESSA INNEHAOLLANDE PHARMACEUTICAL PRODUCT

Legal Events

Date Code Title Description
FC Application refused

Owner name: SCHERING AKTIENGESELLSCHAFT